VESIGEN THERAPEUTICS
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables the delivery of a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and gene-editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets.
VESIGEN THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vesigentx.com
Total Employee:
1+
Status:
Active
Total Funding:
28.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Current Advisors List
Current Employees Featured
Founder
Investors List
Linden Lake Ventures
Linden Lake Ventures investment in Series A - Vesigen Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Vesigen Therapeutics
Morningside Venture Investments
Morningside Venture Investments investment in Series A - Vesigen Therapeutics
Leaps by Bayer
Leaps by Bayer investment in Series A - Vesigen Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-11 | Vesigen Therapeutics Appoints Paulash Mohsen as Chief Executive Officer |
Official Site Inspections
http://www.vesigentx.com
- Host name: 147.61.127.34.bc.googleusercontent.com
- IP address: 34.127.61.147
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
